According to WuXi Biologics's latest financial reports the company's current EPS (TTM) is 0,23 โฌ. In 2021 the company made an earnings per share (EPS) of 0,23 โฌ an increase over its 2020 EPS that were of 0,12 โฌ.
Year | EPS | Change |
---|---|---|
2021 | 0,23 โฌ | 92.81% |
2020 | 0,12 โฌ | 70.58% |
2019 | 0,07134 โฌ | 53.35% |
2018 | 0,04652 โฌ | 104.96% |
2017 | 0,02270 โฌ | 105.9% |
2016 | 0,01102 โฌ | 195.88% |
2015 | 0,003726 โฌ | 1.3% |
2014 | 0,003678 โฌ |